- QMRO Home
- William Harvey Research Institute
- Centre for Translational Medicine & Therapeutics
- Identification of AnnexinA1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes.
Browse
Administrators only